Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 27, 2021

Study Completion Date

January 10, 2022

Conditions
Covid19Neurocognitive Dysfunction
Interventions
DEVICE

Hyperbaric oxygen

Each session will include exposure of 90 minutes to 100% at 2 ATA, with 5 minutes air breaks every 20 minutes

DEVICE

Sham

Each session will include exposure of 90 minutes to 21% at 1.2 ATA during the first five minutes of the session with the noise of circulating air, and then decrease slowly during the next five minutes to 1.03 ATA

Trial Locations (1)

70300

Assaf-Harofeh medical center, Ẕerifin

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT04647656 - Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome | Biotech Hunter | Biotech Hunter